MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
47 hedge funds and large institutions have $9.43M invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
47% less capital invested
Capital invested by funds: $17.8M → $9.43M (-$8.36M)
Holders
47
Holding in Top 10
–
Calls
$1.28M
Puts
$1.22M
Top Buyers
| 1 | +$1.29M | |
| 2 | +$166K | |
| 3 | +$140K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$139K |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$69.3K |
Top Sellers
| 1 | -$953K | |
| 2 | -$826K | |
| 3 | -$607K | |
| 4 |
D.E. Shaw & Co
New York
|
-$357K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$208K |